SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000909518-02-000887
Filing Date
2002-12-27
Accepted
2002-12-27 15:58:56
Documents
4
Group Members
TAKARA HOLDINGS CO. LTD.

Document Format Files

Seq Description Document Type Size
1 jd12-27_13d.txt SC 13D 21448
3 24.1 jd12-27_ex241.txt EX-99 3427
4 24.2 jd12-27_ex242.txt EX-99 3432
5 99.1 jd12-27_ex991.txt EX-99 1443
  Complete submission text file 0000909518-02-000887.txt   31916
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Subject) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45862 | Film No.: 02870367
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address SETA 3-4-1 OTSU SHIGA M0 520-2193
Business Address SETA 3-4-1 OTSU SHIGA M0 520-2193 01181775437235
TAKARA BIO INC (Filed by) CIK: 0001196461 (see all company filings)